examined highly differentiated CD28- CD27- CD4 T (THD) cells using FACS in the peripheral blood of 34 patients with NSCLC both prior to starting and during PD-1/PD-L1 inhibitor treatment. Here, PDCD1 is linked to non-small cell lung carcinoma.